Novadaq Technologies  
Novadaq Technologies Inc(NVDQ.US)成立于2000年，总部位于加拿大安大略，主要从事医学影像系统的研发、生产及销售，包括：SPY影像系统、内视镜萤光影像系统、机器人手术系统及心脏雷射系统，产品主要应用于整型重建外科、腹部外科、心脏外科以及一般外科等。　
其中，「SPY影像系统」主要应用于乳房重建、头颈和大肠直肠专科手术等，协助外科医师评估手术部位灌流不良或不足的组??织。
2009年1月，公司宣布成为「PLC Medical」公司「心脏雷射系统」在北美的独家经销商；同期并与「Intuitive Surgical」联盟，将SPY影像技术及da Vinci Surgical Robotic System(达芬奇手术机器人系统)的3维HD影像功能整合一体。
2010年9月，公司与KCI旗下的「LifeCell ™」公司签订「SPY影像系统」北美独家经销协议。

 Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to radiation. More than 50 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs.

The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.

Novadaq is traded on the NASDAQ Stock Exchange (Sym: NVDQ) and the TSX (Sym: NDQ).